COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,845 Articles (22,553 medRxiv, 8,292 bioRxiv)

Most recent first Previous |  Page 2681: Articles 26801-26810  | Next

Avoiding COVID-19: Aerosol Guidelines
Evans, M.
10.1101/2020.05.21.20108894 — Posted: 2020-05-25
Clinical and molecular characterization of COVID-19 hospitalized patients
Benetti, E., Giliberti, A., Emiliozzi, A., Velentino, F., Bergantini, L., Fallerini, C., Anedda, F., Amitrano, S., Conticini, E., Tita, R., DAlessandro, M., Fava, F., Marcantonio, S., Baldassarri, M., Bruttini, M., Mazzei, M. A., Montagnani, F., Mandala, M., Bargagli, E., Furini, S., COVID-19 MULTICENTER STUDY, , Renieri, A., Mari, F.
10.1101/2020.05.22.20108845 — Posted: 2020-05-25
ASSESSMENT OF WORKERS PERSONAL VULNERABILITY TO COVID-19 USING COVID-AGE
Coggon, D., Croft, P., Cullinan, P., Williams, A.
10.1101/2020.05.21.20108969 — Posted: 2020-05-25
CLINICAL CHARACTERISTICS AND PROGNOSTIC FACTORS FOR ICU ADMISSION OF PATIENTS WITH COVID-19 USING MACHINE LEARNING AND NATURAL LANGUAGE PROCESSING
Izquierdo, J. L., Ancochea, J., Soriano, J. B.
10.1101/2020.05.22.20109959 — Posted: 2020-05-25
COVID-19 Outcomes in 4712 consecutively confirmed SARS-CoV2 cases in the city of Madrid.
Heili-Frades, S., Minguez, P., Mahillo-Fernandez, I., Prieto-Rumeau, T., Herrero Gonzalez, A., de la Fuente, L., Rodriguez Nieto, M. J., Peces-Barba Romero, G., Peces-Barba, M., Carballosa de Miguel, M. d. P., Fernandez Ormaechea, I., Naya Prieto, A., Ezzine de Blas, F., Jimenez Hiscock, L., Perez Calvo, C., Santos, A., Munoz Alameda, L. E., Romero Bueno, F., Hernandez-Mora, M. G., Cabello Ubeda, A., Alvarez Alvarez, B., Petkova, E., Carrasco, N., Martin Rios, D., Gonzalez Mangado, N., Sanchez Pernaute, O.
10.1101/2020.05.22.20109850 — Posted: 2020-05-25 Discussion: Onsite
Association between comorbidities and the risk of death in patients with COVID-19: sex-specific differences
Wu, M., Huang, s., Liu, J., Shu, Y., Luo, Y., Wang, L., Li, M., Wang, Y.
10.1101/2020.05.22.20109579 — Posted: 2020-05-25
Differences of clinical and imaging findings in multiple generations of secondary COVID-19 infection in Xi'an, China
Li, R., Jian, Z., Jin, C., Wang, Y., Liang, T., Liu, Z., Zhao, H., Wang, Z., Zhou, J., Zeng, L., Yang, J.
10.1101/2020.05.23.20109496 — Posted: 2020-05-25
Eat, Pray, Work: A meta-analysis of COVID-19 Transmission Risk in Common Activities of Work and Leisure
Prakash, M. K.
10.1101/2020.05.22.20110726 — Posted: 2020-05-24
Epidemiological monitoring and control perspectives: application of a parsimonious modelling framework to the COVID-19 dynamics in France
Sofonea, M. T., Reyne, B., Elie, B., Djidjou-Demasse, R., Selinger, C., Michalakis, Y., Alizon, S.
10.1101/2020.05.22.20110593 — Posted: 2020-05-24
Effects of Government Mandated Social Distancing Measures on Cumulative Incidence of COVID-19 in the United States and its Most Populated Cities
Krishnamachari, B., Dsida, A., Zastrow, D., Harper, B., Morris, A., Santella, A.
10.1101/2020.05.22.20110460 — Posted: 2020-05-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).